Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

被引：1

作者：

Pan, Xiaohui ^{[1
]}

He, Hongbo ^{[2
,3
]}

Bao, Yuqian ^{[4
]}

Bi, Yan ^{[5
]}

Chen, Luyuan ^{[6
,7
]}

Chen, Xiaoping ^{[8
]}

Fang, Hui ^{[9
]}

Feng, Wenhuan ^{[5
]}

Gao, Ling ^{[10
]}

Guo, Lixin ^{[11
,12
,13
]}

Guo, Yifang ^{[14
]}

Han, Yaling ^{[15
,16
]}

Hua, Qi ^{[17
]}

Li, Nanfang ^{[18
]}

Li, Quanmin ^{[19
]}

Li, Yan ^{[20
,21
]}

Li, Yong ^{[22
]}

Li, Xialian ^{[23
]}

Liu, Jing ^{[24
]}

Ma, Huijuan ^{[25
]}

Mu, Jianjun ^{[26
]}

Nong, Kailei ^{[1
]}

Shang, Huiqian ^{[27
]}

Shen, Yunfeng ^{[28
]}

Shi, Zhongwei ^{[29
]}

Sun, Fang ^{[30
]}

Sun, Ningling ^{[24
]}

Tao, Jun ^{[31
]}

Wang, Jiguang ^{[21
,32
]}

Wang, Xinling ^{[33
]}

Wu, Jing ^{[34
]}

Xiao, Xinhua ^{[35
]}

Xie, Liangdi ^{[36
]}

Xu, Jing ^{[37
,38
]}

Ye, Hongying ^{[39
]}

Yu, Dongni ^{[11
]}

Yuan, Hong ^{[40
]}

Zhang, Huijie ^{[41
]}

Zhang, Jian ^{[42
]}

Zhang, Lili ^{[43
]}

Zhang, Yuqing ^{[44
]}

Zhou, Jiaqiang ^{[45
]}

Zhou, Xinli ^{[46
]}

Zhu, Dalong ^{[5
]}

Zhu, Tiehong ^{[46
]}

Li, Sheyu ^{[1
]}

Zhu, Zhiming ^{[2
,3
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China

[2] Army Med Univ, Chongqing Inst Hypertens, Chongqing, Peoples R China

[3] Chongqing Inst Hypertens, Chongqing, Peoples R China

[4] Shanghai Jiao Tong Univ, Dept Otorhinolaryngol, Peoples Hosp 6, Sch Med, Shanghai, Peoples R China

[5] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol, Nanjing, Peoples R China

[6] Peoples Hosp Guangdong Prov, Dept Cardiol, Guangzhou, Peoples R China

[7] Guangzhou Inst Cardiovasc Dis, Guangzhou, Peoples R China

[8] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China

[9] Hebei Med Univ, Tangshan City Workers Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China

[10] Wuhan Univ, Dept Endocrinol, Renmin Hosp, Wuhan, Peoples R China

[11] Beijing Hosp, Minist Hlth, Dept Endocrinol, Beijing, Peoples R China

[12] China Natl Ctr Bioinformat, Beijing, Peoples R China

[13] Chinese Acad Med Sci, Inst Geriatr, Beijing, Peoples R China

[14] Hebei Gen Hosp, Dept Geriatr Cardiovasc Med, Shijiazhuang, Peoples R China

[15] Gen Hosp Northern Theater Command, Dept Cardiol, Shenyang, Peoples R China

[16] Shenyang Mil Command, Shenyang, Peoples R China

[17] Capital Med Univ, Xuanwu Hosp, Dept Cardiol, Beijing, Peoples R China

[18] Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Urumqi, Peoples R China

[19] PLA Rocket Force Characterist Med Ctr, Dept Endocrinol, Beijing, Peoples R China

[20] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai, Peoples R China

[21] Shanghai Res Inst Hypertens, Shanghai, Peoples R China

[22] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai, Peoples R China

[23] Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou, Peoples R China

[24] Peking Univ Peoples Hosp, Cardiovasc Med Dept, Beijing, Peoples R China

[25] Hebei Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China

[26] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Peoples R China

[27] Zunyi Med Univ, Dept Cardiovasc Med, Affiliated Hosp, Zunyi, Peoples R China

[28] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol & Metab, Shenzhen, Peoples R China

[29] Army Med Univ, Daping Hosp, Army Special Med Ctr, Dept Hypertens & Endocrinol, Chongqing, Peoples R China

[30] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China

[31] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai, Peoples R China

[32] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Endocrinol, Urumqi, Peoples R China

[33] Cent South Univ, Dept Endocrinol, Xiangya Hosp, Changsha, Peoples R China

[34] Univ South China, Affiliated Hosp 1, Dept Endocrinol & Metab, Changsha, Peoples R China

[35] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[36] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Endocrinol, Xian, Peoples R China

[37] Army Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China

[38] Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai, Peoples R China

[39] Cent South Univ, Dept Gynecol, Xiangya Hosp 3, Changsha, Peoples R China

[40] Southern Med Univ, Nanfang Hosp, Dept Endocrinol, Guangzhou, Peoples R China

[41] Hubei Prov Hosp TCM, Dept Encephalopathy, Wuhan, Peoples R China

[42] Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 2, Chongqing, Peoples R China

[43] Chinese Acad Med Sci, Dept Cardiovasc Surg, Fuwai Hosp, Beijing, Peoples R China

[44] Zhejiang Univ, Sir Run Shaw Hosp, Sch Med, Dept Endocrinol & Metab, Hangzhou, Peoples R China

[45] Shandong First Med Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Jinan, Peoples R China

[46] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China

来源：

JOURNAL OF EVIDENCE BASED MEDICINE | 2024年 / 17卷 / 04期

基金：

中国国家自然科学基金;

关键词：

anti-hypertensive treatment; blood pressure monitor; hypertension; screening for hypertension; type; 2; diabetes; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; DISEASE; EFFICACY; SODIUM; HOME; MELLITUS; DYSFUNCTION; INHIBITORS;

D O I：

10.1111/jebm.12655

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

引用

页码：851 / 864

页数：14

共 50 条

[41] Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus
Villanueva, Vicente
Artal, Jesus
Cabeza-Alvarez, Clara-Isabel
Campos, Dulce
Castillo, Ascension
Florez, Gerardo
Franco-Martin, Manuel
Paz Garcia-Portilla, Maria
Giraldez, Beatriz G.
Gotor, Francisco
Gutierrez-Rojas, Luis
Molins Albanell, Albert
Paniagua, Gonzalo
Pintor, Luis
Jose Poza, Juan
Rubio-Granero, Teresa
Toledo, Manuel
Tortosa-Conesa, Diego
Rodriguez-Uranga, Juan
Bobes, Julio
NEUROLOGY AND THERAPY, 2023, 12 (02) : 479 - 503
[42] Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus
Vicente Villanueva
Jesús Artal
Clara-Isabel Cabeza-Alvarez
Dulce Campos
Ascensión Castillo
Gerardo Flórez
Manuel Franco-Martin
María Paz García-Portilla
Beatriz G. Giráldez
Francisco Gotor
Luis Gutiérrez-Rojas
Albert Molins Albanell
Gonzalo Paniagua
Luis Pintor
Juan José Poza
Teresa Rubio-Granero
Manuel Toledo
Diego Tortosa-Conesa
Juan Rodríguez-Uranga
Julio Bobes
Neurology and Therapy, 2023, 12 : 479 - 503
[43] Body Mass Index and Risk for Hypertension of Adults with Type 2 Diabetes Mellitus Body Mass Index and Risk for Hypertension of Adults with Type 2 Diabetes Mellitus
Prakoso, Agung Tri
Wahyono, Tri Yunis Miko
Sibarani, Roy Panusunan
JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 843 - 847
[44] Increasing Prevalence of Type 2 Diabetes in Chinese Adults in Shanghai
Li, Rui
Lu, Wei
Jiang, Qing Wu
Li, Yan Yun
Zhao, Gen Ming
Shi, Liang
Di Yang, Qun
Ruan, Ye
Jiang, Junyi
Zhang, Sheng Nian
Xu, Wang Hong
Zhong, Wei Jian
DIABETES CARE, 2012, 35 (05) : 1028 - 1030
[45] Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults
Bragg, Fiona
Kartsonaki, Christiana
Guo, Yu
Holmes, Michael
Du, Huaidong
Yu, Canqing
Pei, Pei
Yang, Ling
Jin, Donghui
Chen, Yiping
Schmidt, Dan
Avery, Daniel
Lv, Jun
Chen, Junshi
Clarke, Robert
Hill, Michael
Li, Liming
Millwood, Iona
Chen, Zhengming
DIABETES CARE, 2022, 45 (02) : 477 - 480
[46] Management of Type 2 Diabetes in Frail Older Adults
Gulistan Bahat
Serdar Ozkok
Mirko Petrovic
Drugs & Aging, 2023, 40 : 751 - 761
[47] Management of Hyperglycemia in Older Adults with Type 2 Diabetes
Gandhi, Gunjan Y.
Mooradian, Arshag D.
DRUGS & AGING, 2022, 39 (01) : 39 - 58
[48] Management of Type 2 Diabetes in Frail Older Adults
Bahat, Gulistan
Ozkok, Serdar
Petrovic, Mirko
DRUGS & AGING, 2023, 40 (09) : 751 - 761
[49] Pharmacologic Glycemic Management of Type 2 Diabetes in Adults
Lipscombe, Lorraine
Booth, Gillian
Butalia, Sonia
Dasgupta, Kaberi
Eurich, Dean T.
Goldenberg, Ronald
Khan, Nadia
MacCallum, Lori
Shah, Baiju R.
Simpson, Scot
CANADIAN JOURNAL OF DIABETES, 2018, 42 : S88 - S103
[50] Management of hypoglycemia in older adults with type 2 diabetes
Freeman, Jeffrey
POSTGRADUATE MEDICINE, 2019, 131 (04) : 241 - 250

← 1 2 3 4 5 →